Literature DB >> 16868691

Clinico-pathological features of bladder carcinoma: experience from a tertiary care hospital of Pakistan.

Muhammad Rafique1, Abrar A Javed.   

Abstract

UNLABELLED: Bladder carcinoma is most common urological malignancy in Pakistan. The objective of the study was to determine the clinico-pathological characteristics of histologically confirmed bladder carcinoma at a tertiary care hospital of South Punjab, Pakistan.
METHODS: In two hundreds and twenty one patients (172 male and 49 female) bladder carcinoma was diagnosed from Jan 1998 to June 2005. All patients were evaluated with regards to clinical presentation, cystoscopic findings and histo-pathological data.
RESULTS: Male female ratio was 3.5:1. The median age was 58 years (range 18-87 years). 65% men had history of cigarette smoking while 51% women had long history of smokeless tobacco (nasal snuff or chewable) use. Most patients presented with painless hematuria. Primary transitional cell carcinoma was the most common (i.e. 96%) histological variety of bladder carcinoma. 63% patients had muscle invasive disease at the time of presentation. Even in superficial bladder carcinoma, most patients had invasion of lamina propria (pT1 disease).
CONCLUSION: More than 90% of primary bladder carcinoma are of transitional cell variety and over 60% having muscle invasive disease at the time of diagnosis. Even in patients with superficial disease, majority (i.e. 98%) have invasion of lamina propria.

Entities:  

Mesh:

Year:  2006        PMID: 16868691     DOI: 10.1007/s11255-006-6676-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

1.  Interinstitutional comparison of bladder carcinoma surgical pathology report adequacy. A College of American Pathologists Q-Probes Study of 7234 bladder biopsies and curettings in 268 institutions.

Authors:  G N Gephardt; P B Baker
Journal:  Arch Pathol Lab Med       Date:  1995-08       Impact factor: 5.534

2.  Prevalence and pattern of smoking in Pakistan.

Authors:  S E Alam
Journal:  J Pak Med Assoc       Date:  1998-03       Impact factor: 0.781

Review 3.  Carcinoma of the urinary bladder: a review of its diverse morphology.

Authors:  J N Eble; R H Young
Journal:  Semin Diagn Pathol       Date:  1997-05       Impact factor: 3.464

4.  Cancer urinary bladder--5 year experience at Cenar, Quetta.

Authors:  J Nusrat; S R Hamdani; G M Burdy; A Khurshid
Journal:  J Ayub Med Coll Abbottabad       Date:  2001 Apr-Jun

Review 5.  Epidemiology of bladder cancer.

Authors:  D T Silverman; P Hartge; A S Morrison; S S Devesa
Journal:  Hematol Oncol Clin North Am       Date:  1992-02       Impact factor: 3.722

6.  Delay and survival in bladder cancer.

Authors:  D M A Wallace; R T Bryan; J A Dunn; G Begum; S Bathers
Journal:  BJU Int       Date:  2002-06       Impact factor: 5.588

Review 7.  Cancers of the bladder.

Authors:  N Sengupta; Emad Siddiqui; Faiz H Mumtaz
Journal:  J R Soc Promot Health       Date:  2004-09

Review 8.  Mutation of cell cycle regulators and their impact on superficial bladder cancer.

Authors:  F Rabbani; C Cordon-Cardo
Journal:  Urol Clin North Am       Date:  2000-02       Impact factor: 2.241

Review 9.  The natural history of bladder cancer. Implications for therapy.

Authors:  R Lee; M J Droller
Journal:  Urol Clin North Am       Date:  2000-02       Impact factor: 2.241

Review 10.  Gender, racial and age differences in bladder cancer incidence and mortality.

Authors:  Ralph Madeb; Edward M Messing
Journal:  Urol Oncol       Date:  2004 Mar-Apr       Impact factor: 3.498

View more
  2 in total

1.  Pathological Characteristics of Primary Bladder Carcinoma Treated at a Tertiary Care Hospital and Changing Demographics of Bladder Cancer in Sri Lanka.

Authors:  S Sasikumar; K S N Wijayarathna; K A M S Karunaratne; U Gobi; A Pathmeswaran; Anuruddha M Abeygunasekera
Journal:  Adv Urol       Date:  2016-01-14

2.  Role of FGFR3 in Urothelial Carcinoma.

Authors:  Malik Akanksha; Sundaram Sandhya
Journal:  Iran J Pathol       Date:  2019-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.